Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use Celgene's Revlimid (lenalidomide) plus dexamethasone and Takeda's Velcade (bortezomib) plus dexamethasone - have already been tried.

Celgene pays $300m upfront for immunology start-up Delinia

Celgene pays $300m upfront for immunology start-up Delinia Star oncology drug Revlimid (lenalidomide) for blood cancer grew 16% to $1.81bn in the quarter, with follow-up Pomalyst/Innovid (pomalidomide) up 29% to $378m.

Celgene bid to push Revlimid beyond myeloma blocked again

Celgene bid to push Revlimid beyond myeloma blocked again the lymphoma market - which it has previously said could add another $1bn-$1.5bn to Revlimid’s peak sales. ... Revlimid has been a cash cow for Celgene for years and is on course to bring in around $8bn this year.

Takeda gets EU green light for oral myeloma drug

Takeda gets EU green light for oral myeloma drug drug Revlimid (lenalidomide) and dexamethasone in patients with myeloma who have been treated with at least one prior therapy.

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma Imnovid has been given the nod for the treatment of people with relapsed or refractory multiple myeloma who have undergone three previous treatments, including Celgene's Revlimid (lenalidomide) and Takeda's

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics